icon-    folder.gif   Conference Reports for NATAP  
 
  (APASL) 24th Conference of the Asian Pacific
Association for the Study of the Liver
12-15 March, 2014
Brisbane, Australia
Back grey_arrow_rt.gif
 
 
 
Twenty-Eight Day Safety and Efficacy of Tenofovir Alafenamide in Chronic Hepatitis B Patients
 
 
  Reported by Jules Levin
APASL 2014, Brisbane, Australia
 
Edward J. Gane,1 Kosh Agarwal,2 Scott K. Fung,3 Tuan T. Nguyen,4 Wendy Cheng,5 Eric Sicard,6 Stephen D. Ryder,7 John F. Flaherty,8 Eileen Lawson,8 Sally Zhao,8 Mani Subramanian,8 John G. McHutchison,8 Graham R. Foster9
1Auckland Clinical Studies, Auckland, New Zealand; 2Institute of Liver Studies, Kings College Hospital, London, UK; 3Toronto General Hospital, Toronto, Ontario, Canada; 4T. Nguyen Research and Education, San Diego, CA, USA; 5Royal Perth Hospital, Perth, Western Australia, Australia;
6Algorithme Pharma, Montreal, Quebec, Canada; 7Nottingham University Hospitals NHS Trust and Biomedical Research Unit, Nottingham, UK; 8Gilead Sciences, Inc., Foster City, CA, USA; 9Queen Mary's University of London, Barts Health, UK

APASL1.gif

APASL2.gif

APASL3.gif

APASL4.gif

APASL5.gif

APASL6.gif

APASL7.gif

APASL8.gif